Search Results - "Priest, David H"

Loiasis in US Traveler Returning from Bioko Island, Equatorial Guinea, 2016 by Priest, David H, Nutman, Thomas B

“…The filarial parasite Loa loa overlaps geographically with Onchocera volvulus and Wuchereria bancrofti filariae in central Africa. Accurate information…”
Get full text

Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility–Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure by Johnson, Steven W, Brown, Shannon V, Priest, David H

“…Abstract Background Limited retrospective data suggest prophylactic oral vancomycin may prevent Clostridioides difficile infection (CDI). We sought to evaluate…”
Get full text

Secondary immune thrombocytopenia (ITP) as an initial presentation of Whipple’s disease by Priest, David H., Grote, Thomas H., Staley, Sallie L., Berger, William S., Norman, Elizabeth S., Smith, Brian S.

“…Immune thrombocytopenia (ITP) is a heterogeneous autoimmune disease characterized by low platelet count that has been associated with a number of chronic…”
Get full text

Reply to McCreery et al by Johnson, Steven W, Brown, Shannon V, Priest, David H

Get full text

When Should Oral Vancomycin Prophylaxis be Used to Prevent C. difficile Infection? by Darkow, Andrew, Johnson, Steven, Walker, Harrison, Priest, David H.

“…Purpose of Review It is unclear if oral vancomycin prophylaxis (OVP) should be used to reduce the risk of Clostridioides difficile infection (CDI) during…”
Get full text

Screening for hepatitis C as part of an opioid stewardship quality improvement initiative: Identifying infected patients and analyzing linkage to care by DeCamillis, Rebekah B, Hekman, Aliza L, Priest, David H

“…Screening patients with opioid use disorder (OUD) for HCV can potentially decrease morbidity and mortality if HCV-infected individuals are linked to care. We…”
Get full text

Use of Intermittent Rifampin and Pyrazinamide Therapy for Latent Tuberculosis Infection in a Targeted Tuberculin Testing Program by Priest, David H., Vossel, Louis F., Sherfy, Elizabeth A., Hoy, Debbie P., Haley, Connie A.

“…Background. To determine the rates of hepatotoxicity and treatment completion associated with intermittent rifampin and pyrazinamide (RZ) therapy for latent…”
Get full text

A regional collaboration between competing healthcare systems to establish influenza season parameters by Priest, David H, DeCamp-Freeze, Susan L, Snider, Cynthia B, Morgan, Melissa G, Garner, Misty D, Givner, Laurence B, Passaretti, Catherine L, McQuaigue, Andrea B

“…To the Editor—Collaborative public health partnerships between competing healthcare system hospitals are uncommon in today’s healthcare environment, despite…”
Get full text

Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach by Johnson, Steven W, Ammirati, Shelby R, Hartis, Charles E, Weber, Stephen F, Morgan, Michael R, Darnell, Timothy A, Silwal, Adwait, Schmidlin, Holly N, Priest, David H

“…Highlights • Real-world data on the use of ledipasvir/sofosbuvir are limited. • Data support interprofessional management of hepatitis C virus. • Sustained…”
Get full text

Infectious Disease Images on the World Wide Web by Yu, Victor L., Priest, David H., Williams, Stephen J.

“…Infectious diseases (ID) physicians are often in need of medical images to enhance their teaching, research, and clinical practice. We explored the Internet…”
Get full text

Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult : Clinical features and therapeutic outcomes by PRIEST, David H, PEACOCK, James E

“…Staphylococcus aureus is the most common cause of hematogenous vertebral osteomyelitis in adults. To better define clinical features and therapeutic outcomes,…”
Get full text

1250. Screening for Hepatitis C as Part of an Opioid Stewardship Initiative: Identifying Infected Patients and Analyzing Linkage to Care by DeCamillis, Becky, Hekman, Aliza, Priest, David H

“…Abstract Background Hepatitis C (HCV) remains a major cause of liver-related morbidity and mortality even though direct-acting antiviral drugs (DAAs) are…”
Get full text

Bamlanivimab for the Prevention of Hospitalizations and Emergency Department Visits in SARS-CoV-2–Positive Patients in a Regional Health Care System by Priest, David H., Blanchette, Lisa M., Hekman, Aliza L., Maddikunta, Rahul, Burleson, Paula E.

“…Introduction Bamlanivimab (LY-CoV555) was approved by Emergency Use Authorization by the United States Food and Drug Administration in the ambulatory setting…”
Get full text

2414. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in High-Risk Patients by Johnson, Steven W, Priest, David H, Brown, Shannon V

“…Abstract Background Studies suggest oral vancomycin prophylaxis may be effective in preventing Clostridioides difficile infection. These studies are limited by…”
Get full text

Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing program. Commentary by PRIEST, David H, VOSSEL, Louis F, SHERRY, Elizabeth A, HOY, Debbie P, HALEY, Connie A, BLUMBERG, Henry M

Get full text

Loiasis in US Traveler Returning from Bioko Island, Equatorial Guinea, 2016 by Priest, David H, Nutman, Thomas B

“…The filarial parasite Loa loa overlaps geographically with Onchocera volvulus and Wuchereria bancrofti filariae in central Africa. Accurate information…”
Get full text